Reclast (zoledronic acid) is a once-yearly intravenous bisphosphonate used in the management of osteoporosis to slow bone loss, increase bone density, and reduce the risk of fractures of the spine, hip, and other sites. A single 15-minute infusion covers a full year, which makes it a practical choice for people who cannot take, tolerate, or remember oral osteoporosis tablets. This guide explains how Reclast works, who is a good candidate, what to expect on infusion day, and the safety checks that keep treatment on track.
Reclast is one of several ways to treat osteoporosis, and it works best as part of a wider plan that includes calcium, vitamin D, exercise, and fall prevention.
What Is Reclast and How Does It Work?
Reclast belongs to the bisphosphonate family, the same drug class as alendronate and risedronate. Its active ingredient, zoledronic acid, is the most potent member of the class. The same molecule is sold at a different dose and schedule under another brand name for cancer-related bone disease, so the Reclast label specifically refers to the osteoporosis regimen.
Bone is living tissue that is constantly remodeled. Osteoclasts break old bone down, and osteoblasts lay new bone down. In osteoporosis, breakdown outpaces rebuilding. Zoledronic acid binds tightly to the bone surface, and when osteoclasts try to resorb that bone they take up the drug, which switches off their activity. Because the drug stays bound in the skeleton for a long time, one dose continues to act for many months.
Who Is a Candidate for Reclast?
Osteoporosis is diagnosed with a DEXA scan (dual-energy X-ray absorptiometry). The table below shows the standard T-score categories used for postmenopausal women and men over 50.
| T-score | Category | Typical approach |
|---|---|---|
| -1.0 and above | Normal bone density | Healthy lifestyle; no medication for bone density alone |
| Between -1.0 and -2.5 | Low bone mass (osteopenia) | Medication considered when fracture risk, such as a FRAX estimate, is high |
| -2.5 and below | Osteoporosis | Medication generally recommended |
| Any score plus a fragility fracture of the hip or spine | Clinical osteoporosis | Medication recommended regardless of T-score |
Reclast is approved for postmenopausal osteoporosis, osteoporosis in men, glucocorticoid-induced osteoporosis, and after a hip fracture. It is also used for Paget’s disease of bone. Although most patients are older adults, bone loss can occur at any age, and young people are assessed differently; our article on juvenile osteoporosis diagnosis and treatment covers that group.
In my practice, Reclast is especially useful for patients who:
- Have reflux, swallowing problems, or other gastrointestinal intolerance to oral bisphosphonates.
- Cannot sit or stand upright for 30 to 60 minutes after a tablet, as oral bisphosphonates require.
- Take many other medicines and find weekly or monthly tablets hard to manage.
- Have just had a hip fracture and need reliable treatment started.
What to Expect on Infusion Day
The standard osteoporosis dose is 5 mg of zoledronic acid given intravenously over no less than 15 minutes, once a year. For prevention in some postmenopausal women with low bone mass, it may be given once every two years.
Before the infusion, your care team checks kidney function and blood calcium, and confirms vitamin D is adequate. Low calcium or vitamin D must be corrected first, because the drug can push calcium levels down further. You will be asked to drink a couple of glasses of fluid beforehand, since good hydration protects the kidneys.
The infusion itself is quick. Most people go home straight afterward and resume normal activities the same day.
Side Effects and Safety Considerations
The most common problem is an acute phase reaction: flu-like symptoms such as fever, muscle aches, joint pain, headache, and tiredness that begin within about three days of the infusion. It is most likely after the first dose and usually settles within a few days. Acetaminophen can ease symptoms, and reactions tend to be milder or absent with later infusions.
Less common but important concerns include:
- Kidney effects: Reclast is not given when creatinine clearance is below 35 mL/min, and kidney function is checked before each dose.
- Low calcium (hypocalcemia): must be corrected before treatment.
- Osteonecrosis of the jaw: rare at osteoporosis doses; risk is higher with invasive dental work, so a dental check before starting is sensible.
- Atypical femoral fractures: rare thigh-bone fractures linked to long-term bisphosphonate use; new groin or thigh pain should be reported.
- Eye inflammation: uncommon, but eye pain or redness needs prompt review.
Reclast should not be used in pregnancy. Ongoing bone or joint pain deserves its own assessment, and our guide to osteoporosis pain treatment covers the options.
How Long Should Treatment Last?
Because zoledronic acid remains in bone, its effect persists after infusions stop. Many clinicians reassess after about three yearly doses. People at lower fracture risk may take a planned break, often called a drug holiday, with repeat DEXA scans to monitor. Those at high risk, such as people with previous spine fractures or very low T-scores, may continue for longer.
Reclast does not replace the basics. Adequate calcium and vitamin D, regular weight-bearing and muscle-strengthening exercise, not smoking, limiting alcohol, and reducing fall hazards at home all add to the protection the drug provides. For a broader overview of the condition, visit our osteoporosis guide.
Key Takeaways
- Reclast is zoledronic acid, a potent bisphosphonate given as a single 5 mg infusion once a year.
- It reduces bone breakdown and lowers the risk of spine, hip, and other fractures.
- It suits people who cannot tolerate or keep up with oral bisphosphonates.
- Kidney function, calcium, and vitamin D must be checked before each dose.
- Flu-like symptoms after the first infusion are common and short-lived; serious side effects are rare.
Frequently Asked Questions
Is Reclast better than Fosamax?
Both are bisphosphonates that reduce fracture risk. Reclast is given once a year by infusion, while Fosamax (alendronate) is a weekly tablet with strict instructions about taking it. The better choice depends on your kidney function, digestive health, and whether you prefer a yearly infusion or a tablet.
How long do the flu-like side effects last?
Symptoms usually start within a few days of the infusion and settle within about three days. They are most common after the first dose. Staying well hydrated and taking acetaminophen if advised can make them easier to manage.
Can I have dental work while on Reclast?
Routine dental care such as cleanings and fillings is encouraged. Before starting, it is sensible to complete any major dental work. If extractions or implants are needed later, let your dentist know you have received zoledronic acid so they can plan accordingly.
Do I still need calcium and vitamin D?
Yes. Reclast relies on adequate calcium and vitamin D to work properly and to avoid low calcium after the infusion. Your doctor will advise on dietary sources and whether supplements are needed.
